Valuation: Teyi Pharmaceutical Group Co.,Ltd

Market Cap 4.76B 702M 612M 564M 523M 995M 66.92B 1.01B 6.74B 2.62B 32.8B 2.63B 2.58B 114B P/E 2024
224x
P/E 2025 67.8x
Enterprise Value 4.69B 691M 603M 555M 515M 980M 65.9B 993M 6.63B 2.58B 32.3B 2.59B 2.54B 112B EV / Sales 2024
6.57x
EV / Sales 2025 5.78x
Free-Float
60.48%
Yield 2024
0.56%
Yield 2025 1.38%
1 day+1.71%
1 week+19.12%
Current month+4.15%
1 month+12.38%
3 months-13.36%
6 months-16.40%
Current year-12.17%
1 week 8.8
Extreme 8.8
10.04
1 month 7.66
Extreme 7.66
10.04
Current year 7.66
Extreme 7.66
14.47
1 year 7.66
Extreme 7.66
15.21
3 years 6.79
Extreme 6.79
17.49
5 years 5.64
Extreme 5.6429
19.64
10 years 5.01
Extreme 5.0102
20.4
Manager TitleAgeSince
Chief Executive Officer 34 2025-07-15
Director of Finance/CFO 54 2009-06-14
Corporate Officer/Principal 43 2020-05-31
Director TitleAgeSince
Director/Board Member 54 2009-06-14
Director/Board Member 43 2022-06-26
Chairman 34 2025-07-15
Date Insider Type Main position Quantity % Market Cap.
24-02-06Buy

Chief Financial Officer

42,000 0.0188%
23-06-13Buy

Chief Financial Officer

42,000 0.0188%
Change 5-day change 1-year change 3-year change Capi.($)
+1.71%+19.12%+9.67%-12.63% 690M
-1.14%-0.67%+53.72%+157.69% 1,082B
-1.41%+1.83%+66.23%+59.28% 633B
-2.42%+0.56%+34.59%+85.12% 461B
-0.26%+1.37%+31.00%+23.05% 338B
-2.46%-1.52%+36.42%+32.77% 299B
-2.20%-0.93%+27.50%+40.62% 291B
-1.77%+0.99%-28.85%-41.41% 222B
-2.06%+2.26%+22.87%+62.23% 202B
-1.26%+1.35%+15.98%+67.80% 163B
Average -0.17%+4.42%+26.91%+47.45% 369.31B
Weighted average by Cap. +0.05%+5.43%+39.61%+78.90%

Financials

2024 2025
Net sales 688M 101M 88.4M 81.43M 75.51M 144M 9.67B 146M 973M 379M 4.74B 381M 372M 16.43B 925M 136M 119M 109M 102M 193M 13B 196M 1.31B 509M 6.37B 512M 500M 22.08B
Net income 20.5M 3.02M 2.63M 2.43M 2.25M 4.28M 288M 4.34M 29M 11.29M 141M 11.34M 11.09M 489M 81.67M 12.04M 10.5M 9.67M 8.97M 17.07M 1.15B 17.3M 116M 44.98M 563M 45.2M 44.21M 1.95B
Net Debt 58.68M 8.65M 7.54M 6.95M 6.44M 12.26M 825M 12.43M 83.02M 32.32M 404M 32.47M 31.76M 1.4B -72.61M -10.7M -9.33M -8.6M -7.97M -15.17M -1.02B -15.38M -103M -39.99M -500M -40.18M -39.3M -1.73B
Logo Teyi Pharmaceutical Group Co.,Ltd
Teyi Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research, development, production, and sales of traditional Chinese medicine preparations, chemical pharmaceutical preparations, and chemical raw materials. The Company's products cover respiratory system, cardiovascular system, digestive system, dermatology, pediatrics, tonics, hypoglycemic agents, and wind-dispelling and dampness-removing agents. The Company's main products include Zhikebao Pian, Ganmaoling Keli, Yinxingye Fensanpian, Yixinshu Keli, Hydrotalcite Chewable Tablets, Omeprazole Enteric Capsules and others. The Company primarily conducts its businesses in domestic market.
Employees
1,434
Date Price Change Volume
26-07-06 CN¥9.530 +1.71% 32,302,404
26-07-03 CN¥9.370 -0.21% 31,171,777
26-07-02 CN¥9.390 -2.29% 44,170,419
26-07-01 CN¥9.610 +5.03% 55,557,705
26-06-30 CN¥9.150 +3.98% 52,292,430

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002728 Stock